* To whom correspondences should be addressed: Prof. Dr. Thomas Happe, AG Photobiotechnologie, Lehrstuhl für Biochemie der Pflanzen, Ruhr Universität Bochum, Universitätsstr. 150, 44801 Bochum, Germany.E-mail: thomas.happe@rub.de, Phone: +49 (0) 23 43 22 70 26. Table S1 : Mutagenic primers used in this study. Table S2 : Iron content of apoHydA1 and holoHydA1 variants after 1 h and 30 h in vitro maturation. Electronic Supplementary Material (ESI) for Chemical Science. This journal is © The Royal Society of Chemistry 2017 In vivo maturation and hydrogen oxidation screening. In order to obtain in vivo maturated HydA1, pET-21(b)-hyda1 plasmid coding for HydA1 or one of its variants was co-transformed with the maturation plasmid pACYCDuet-1-hydGX-hydEF into Escherichia coli strain BL21(DE3)ΔiscR. Single colonies were transferred to LB-Agar plates supplemented with 100 mM MOPS/NaOH (pH 7.4), 25 mM sodium fumarate, 0.5 % glucose, and 2 mM ferric ammonium citrate as well as the antibiotics kanamycin (40 mg/mL), chloramphenicol (25mg/mL) and ampicillin (100 mg/mL) in analogy to the liquid medium used for apoHydA1 expression. Once single colonies had a diameter of roughly 3 mm, plates were transferred into an anaerobic environment (2 % H 2 / 98 % N 2 ) and protein expression was induced by adding dropwise 2 µL of 5 mM Isopropyl-β-D-thiogalactopyranosid in 500 mM L-cystein per colony. After incubation for 20 h at room temperature enzymatic activity was assayed by adding dropwise 2 µL of MV per colony prior to an incubation under 10 % H 2 / 90 % N 2 atmosphere for 10 min. Colonies eventually turned blue due to specific reduction of MV by HydA1 WT and variants performing H 2 oxidation under the given conditions. Figure S3 : Annotated FTIR spectra of holoHydA1 variants. Spectra of C170D, C170S, C362D, and C362S variants without further treatment ("as purified") and after 15 min CO flushing ("CO-inhibited").
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Representative spectra of in vitro maturated C170S and C362S samples for 30 h and C170D and C362D for 1 h. Sample concentration varied between 1 and 2.1 mM. Spectra were measured at 15 °C in 100 mM Tris-HCl buffer (pH 8) with 2 mM NaDT.
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Figure S4: Comparison of normalized FTIR spectra of holoHydA1 variants after 1 h and 30 h in vitro maturation. FTIR spectra of holoHydA1 variants without further treatment after 1 h (black) and 30 h (red) in vitro maturation. Spectra were normalized to the same enzyme concentration (1 mM). Spectra were measured at 15 °C in 100 mM Tris-HCl buffer (pH 8) with 2 mM NaDT. Sample concentration varied between 0.7 and 2.1 mM.
Figure S5:
In vitro maturation followed by FTIR over 30 h. A 5-fold molar excess of [2Fe] MIM was used and maturation followed at 2013 cm -1 . Spectra were measured at 25 °C in 100 mM Tris-HCl buffer (pH 8) with 2 mM NaDT. Sample concentration were 1 and 0.8 mM for C170S and C362S, respectively.
In vitro maturation followed by FTIR spectroscopy. A 5-fold molar excess of [2Fe] MIM was added to 800-1000 µM apoHydA1 in 100mM 100 mM Tris-HCl buffer (pH 8) with 2 mM NaDT initiating the maturation process. Sample was closed in the transmission FTIR cell and transferred to FTIR spectrometer where maturation process was constantly followed at 2013 cm -1 . Spectra were detected at 25 °C. Initially, spectra were accumulated for 100 (80 s) then 500 (6.5 min) and finally 1000 scans (around 13 min). The 4 variants were also measured at pH 4 but any of them showed catalytic current (not shown). All experimental conditions were the same as in Fig. 4 of the main text.
